Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline pharmacologic prevention in heavy smokers undergoing lung cancer screening
2009-014301-14Phase 3Completed
- Sponsor
- Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of varenicline in nicotine dependence and bronchial carcinoma (2 arms), sponsored by Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano. Primary endpoint: Smoking cessation at follow-up. Started Aug 2009; status: completed.
02
Drugs
varenicline
03
Conditions
nicotine dependencebronchial carcinoma
Beyond the preview
Go deeper on 2009-014301-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014301-14.